Hypertension and traditional risk factors for cardiovascular diseases among treatment naive HIV- infected adults initiating antiretroviral therapy in Urban Tanzania

被引:3
|
作者
Mwakyandile, Tosi M. [1 ]
Shayo, Grace A. [2 ]
Sasi, Philip G. [1 ]
Mugusi, Ferdinand M. [2 ]
Barabona, Godfrey [3 ]
Ueno, Takamasa [3 ,5 ]
Lyamuya, Eligius F. [4 ,5 ]
机构
[1] Muhimbili Univ Hlth & Allied Sci MUHAS, Sch Biomed Sci, Dept Clin Pharmacol, Campus Coll Med, Dar Es Salaam, Tanzania
[2] Muhimbili Univ Hlth & Allied Sci MUHAS, Sch Clin Med, Dept Internal Med, Campus Coll Med, Dar Es Salaam, Tanzania
[3] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Infect & Immun, Kumamoto, Japan
[4] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Collaborat Unit Infect, Kumamoto, Japan
[5] Muhimbili Univ Hlth & Allied Sci MUHAS, Sch Diagnost Med, Dept Microbiol & Immunol, Campus Coll Med, Dar Es Salaam, Tanzania
基金
日本学术振兴会; 美国国家卫生研究院;
关键词
Dyslipidaemia; Obesity; Hypertension; Diabetes mellitus; Cardiovascular diseases; HIV; Antiretroviral therapy; Tanzania; PREVALENCE; ERA; MORTALITY; COHORT; DEATH;
D O I
10.1186/s12872-023-03332-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundCardiovascular diseases (CVDs) have become an important cause of ill health and death among people living with HIV and/or AIDS (PLHIV) in the antiretroviral therapy (ART) era. There is scarce data on the burden of hypertension (HTN) and risk factors for CVDs among PLHIV in developing countries, including Tanzania during the ART era.Objective(s)To determine the prevalence of HTN and risk factors for CVDs among ART naive PLHIV initiating ART.MethodsWe analysed baseline data of 430 clinical trial participants on the effect of low-dose aspirin on HIV disease progression among HIV-infected individuals initiating ART. HTN was the outcome CVD. Traditional risk factors for CVDs studied were age, alcohol consumption, cigarette smoking, individual and family history of CVDs, diabetes mellitus (DM), obesity/overweight, and dyslipidaemia. A generalized linear model (robust Poisson regression) was used to determine the predictors for HTN.ResultsThe median (IQR) age was 37 (28, 45) years. Females were the majority contributing 64.9% of all participants. The prevalence of HTN was 24.8%. The most prevalent risk factors for CVDs were dyslipidaemia (88.3%), alcohol consumption (49.3%), and overweight or obesity (29.1%). Being overweight or obese predicted the occurrence of HTN, aPR 1.60 (95% CI 1.16-2.21) while WHO HIV clinical stage 3 was protective against HTN, aPR 0.42(95% CI 0.18-0.97).ConclusionThe prevalence of HTN and traditional risk factors for CVDs in the treatment naive PLHIV initiating ART are significant. Identifying these risk factors and managing them at the time of ART initiation may lower future CVDs among PLHIV.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Incidence and Risk Factors for Invasive Pneumococcal Disease in HIV-Infected and Non-HIV-Infected Individuals Before and After the Introduction of Combination Antiretroviral Therapy: Persistent High Risk Among HIV-Infected Injecting Drug Users
    Harboe, Zitta Barrella
    Larsen, Mette Vang
    Ladelund, Steen
    Kronborg, Gitte
    Konradsen, Helle Bossen
    Gerstoft, Jan
    Larsen, Carsten Schade
    Pedersen, Court
    Pedersen, Gitte
    Obel, Niels
    Benfield, Thomas
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (08) : 1168 - 1176
  • [42] Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults
    Siegfried, Nandi
    Uthman, Olalekan A.
    Rutherford, George W.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (03):
  • [43] Hypertension among adults enrolled in HIV care in northern Tanzania: comorbidities, cardiovascular risk, and knowledge, attitudes and practices
    Manavalan, Preeti
    Madut, Deng Buok
    Hertz, Julian Thornton
    Thielman, Nathan Maclyn
    Okeke, Nwora Lance
    Mmbaga, Blandina Theophil
    Watt, Melissa Harper
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [44] Prevalence and risk factors of hypertension in HIV-positive adults on antiretroviral therapy in Ondo State, Nigeria
    Ilesanmi, Olayinka S.
    Akpa, Onoja M.
    HIV & AIDS REVIEW, 2020, 19 (03): : 199 - 205
  • [45] Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve, Escor N.
    Kayabu, David
    Nassari, Nahum O.
    Todd, Jim
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 (06) : 791 - 796
  • [46] Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults
    Shivakoti, Rupak
    Christian, Parul
    Yang, Wei-Teng
    Gupte, Nikhil
    Mwelase, Noluthando
    Kanyama, Cecilia
    Pillay, Sandy
    Samaneka, Wadzanai
    Santos, Breno
    Poongulali, Selvamuthu
    Tripathy, Srikanth
    Riviere, Cynthia
    Berendes, Sima
    Lama, Javier R.
    Cardoso, Sandra W.
    Sugandhavesa, Patcharaphan
    Tang, Alice M.
    Semba, Richard D.
    Campbell, Thomas B.
    Gupta, Amita
    CLINICAL NUTRITION, 2016, 35 (01) : 183 - 189
  • [47] Magnitude and associated factors of cytopenias among antiretroviral therapy naive Human Immunodeficiency Virus infected adults in Dessie, Northeast Ethiopia
    Tamir, Zemenu
    Seid, Abdurahaman
    Haileslassie, Haftay
    PLOS ONE, 2019, 14 (02):
  • [48] Factors associated with 36-month loss to follow-up and mortality outcomes among HIV-infected adults on antiretroviral therapy in Central Kenya
    Wekesa, Paul
    McLigeyo, Angela
    Owuor, Kevin
    Mwangi, Jonathan
    Nganga, Evelyne
    Masamaro, Kenneth
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [49] Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men
    Paccou, J.
    Viget, N.
    Drumez, E.
    Cortet, B.
    Robineau, O.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (07): : 442 - 448
  • [50] HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults
    Lipshultz, Steven E.
    Mas, Catherine M.
    Henkel, Jacqueline M.
    Franco, Vivian I.
    Fisher, Stacy D.
    Miller, Tracie L.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (06) : 661 - 674